A Multi-Center, Double-Blind Randomized Controlled Phase III Clinical Trial to Evaluate the Antiviral Activity and Safety of DA-2802 (Tenofovir Disoproxil Orotate) and Viread (Tenofovir Disoproxil Fumarate) in Chronic Hepatitis B Patients

BACKGROUND: Tenofovir disoproxil fumarate (TDF, Viread(®)) had been used as a standard treatment option of chronic hepatitis B (CHB). This clinical trial was conducted to evaluate the efficacy and safety of DA-2802 (tenofovir disoproxil orotate) compared to TDF. METHODS: The present study was a doub...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hyung Joon, Kim, Ju Hyun, Yeon, Jong Eun, Seo, Yeon Seok, Jang, Jeong Won, Cho, Yong Kyun, Jang, Byoung Kuk, Han, Byung Hoon, Lee, Changhyeong, Lee, Joon Hyeok, Yoon, Jung-Hwan, Kim, Kang Mo, Kim, Moon Young, Kim, Do Young, Park, Neung Hwa, Cho, Eun Young, Lee, June Sung, Lee, Jin-Woo, Kim, In Hee, Song, Byung-Cheol, Lee, Byung-Seok, Kwon, Oh Sang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8938614/
https://www.ncbi.nlm.nih.gov/pubmed/35315603
http://dx.doi.org/10.3346/jkms.2022.37.e92

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8938614/
https://www.ncbi.nlm.nih.gov/pubmed/35315603
http://dx.doi.org/10.3346/jkms.2022.37.e92

Ejemplares similares